ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME
The antiphospholipid antibodies (APA) exert multiple effects on the hemostasis system causing damage to all of its protective components including the endothelial barrier, natural anticoagulant function and endogenous fibrinolysis and activating the platelet phase of hemostasis, which is associated...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2016-06-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/58 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849697270153347072 |
|---|---|
| author | J. Kh. Khizroeva T. M. Mashkova |
| author_facet | J. Kh. Khizroeva T. M. Mashkova |
| author_sort | J. Kh. Khizroeva |
| collection | DOAJ |
| description | The antiphospholipid antibodies (APA) exert multiple effects on the hemostasis system causing damage to all of its protective components including the endothelial barrier, natural anticoagulant function and endogenous fibrinolysis and activating the platelet phase of hemostasis, which is associated with numerous obstetrical complications andinfertility. The question is, what is the frequency of circulating APA in women who underwent IVF failure and whether there is a relationship between the presence of APA and poor reproduction outcome? This study aimed at elucidating the effect of the presence of APA on the outcomes of assisted reproductive technology (ART). A total of 267 women diagnosed with infertility and planning to get pregnant using the assisted reproductive technology (ART) have been examined. The results of examination demonstrated a high prevalence of circulating APA in a group of women who underwent IVF failure. High titers of APA were found in 42.1% of female patients who had undergone IVF failure. The fraction of women in whom fertility treatment using ART succeeded was 19.1%. |
| format | Article |
| id | doaj-art-36f28cbe67cf4c669d91f22c69b0b8bd |
| institution | DOAJ |
| issn | 2313-7347 2500-3194 |
| language | Russian |
| publishDate | 2016-06-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Акушерство, гинекология и репродукция |
| spelling | doaj-art-36f28cbe67cf4c669d91f22c69b0b8bd2025-08-20T03:19:15ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942016-06-0181263057ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROMEJ. Kh. Khizroeva0T. M. Mashkova1Chair of Obstetrics and Gynaecology of Medical Prophylaxis Faculty of I.M. Sechenov First Moscow State Medical UniversityChair of Obstetrics and Gynaecology of Medical Prophylaxis Faculty of I.M. Sechenov First Moscow State Medical UniversityThe antiphospholipid antibodies (APA) exert multiple effects on the hemostasis system causing damage to all of its protective components including the endothelial barrier, natural anticoagulant function and endogenous fibrinolysis and activating the platelet phase of hemostasis, which is associated with numerous obstetrical complications andinfertility. The question is, what is the frequency of circulating APA in women who underwent IVF failure and whether there is a relationship between the presence of APA and poor reproduction outcome? This study aimed at elucidating the effect of the presence of APA on the outcomes of assisted reproductive technology (ART). A total of 267 women diagnosed with infertility and planning to get pregnant using the assisted reproductive technology (ART) have been examined. The results of examination demonstrated a high prevalence of circulating APA in a group of women who underwent IVF failure. High titers of APA were found in 42.1% of female patients who had undergone IVF failure. The fraction of women in whom fertility treatment using ART succeeded was 19.1%.https://www.gynecology.su/jour/article/view/58antiphospholipid antibodiesthrombophiliaassisted reproductive technologyin-vitro fertilizationivf implantation failure |
| spellingShingle | J. Kh. Khizroeva T. M. Mashkova ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME Акушерство, гинекология и репродукция antiphospholipid antibodies thrombophilia assisted reproductive technology in-vitro fertilization ivf implantation failure |
| title | ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME |
| title_full | ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME |
| title_fullStr | ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME |
| title_full_unstemmed | ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME |
| title_short | ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME |
| title_sort | assisted reproductive technology and antiphospholipid syndrome |
| topic | antiphospholipid antibodies thrombophilia assisted reproductive technology in-vitro fertilization ivf implantation failure |
| url | https://www.gynecology.su/jour/article/view/58 |
| work_keys_str_mv | AT jkhkhizroeva assistedreproductivetechnologyandantiphospholipidsyndrome AT tmmashkova assistedreproductivetechnologyandantiphospholipidsyndrome |